Avi Avramoff

Chief Tech/Sci/R&D Officer en TARO PHARMACEUTICAL INDUSTRIES LTD. .

59 años

Health Technology

Perfil

Avi Avramoff is currently the Vice President & Head of Research & Development at Taro Pharmaceutical Industries Ltd.
Prior to his current position, he served as the Vice President of Research & Development at Dexcel Pharma Technologies Ltd.
from 1994 to 2011.

Cargos activos de Avi Avramoff

Empresas	Cargo	Inicio
TARO PHARMACEUTICAL INDUSTRIES LTD.	Chief Tech/Sci/R&D Officer	01/10/2011

Todos los cargos activos de Avi Avramoff

Antiguos cargos conocidos de Avi Avramoff.

Empresas	Cargo	Fin
Dexcel Pharma Technologies Ltd. Dexcel Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Dexcel Pharma Technologies Ltd. develops, manufactures and markets branded and generic pharmaceuticals. Its core products include Deximune, PerioChip, and Omeprazole delayed released tablet. The company was founded by Dan Oren in 1968 and is headquartered in Or Akiva, Israel.	Chief Tech/Sci/R&D Officer	01/01/2011

Ver el detalle de la experiencia de Avi Avramoff.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Avi Avramoff.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
TARO PHARMACEUTICAL INDUSTRIES LTD.	Health Technology

Empresas privadas	1
Dexcel Pharma Technologies Ltd. Dexcel Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Dexcel Pharma Technologies Ltd. develops, manufactures and markets branded and generic pharmaceuticals. Its core products include Deximune, PerioChip, and Omeprazole delayed released tablet. The company was founded by Dan Oren in 1968 and is headquartered in Or Akiva, Israel.	Health Technology

Ver las conexiones de la empresa